Last reviewed: June 18, 2026
Last updated: June 18, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works through a carefully planned dosing schedule that typically starts at 0.25 mg weekly and increases over 16 to 20 weeks. Your body's response to each dose determines whether adjustments are needed, making personalized monitoring essential to your success.
Understanding Semaglutide Dose Escalation Schedules
Semaglutide follows a standardized titration protocol designed to allow your body to adapt gradually. Most patients begin with a 0.25 mg injection once per week, then progress to 0.5 mg in week five. This slow-and-steady approach reduces nausea, vomiting, and gastrointestinal discomfort that might otherwise lead to treatment discontinuation.
The dose ladder continues with increases at four-week intervals: 1.0 mg by week nine, 1.7 mg by week thirteen, and 2.0 mg by week seventeen. However, individual tolerance varies significantly—some patients feel optimal at 1.0 mg, while others require the full 2.0 mg maintenance dose. Your prescriber monitors your weight loss progress and symptom profile to determine if you should continue advancing.
Average Maintenance Doses Across Clinical Trials
The STEP trials, which established semaglutide's efficacy for chronic weight management, demonstrated that patients at the 2.4 mg weekly dose achieved the greatest average weight loss—approximately 15% of body weight over 68 weeks. However, not all patients require or tolerate this maximum dose; many reach their weight loss goal at 1.7 mg or 1.0 mg weekly.
Real-world prescribing data shows approximately 60% of patients remain on 1.7 mg or 2.0 mg, while 25% stabilize at 1.0 mg, and 15% require dose reduction due to side effects. This distribution underscores why the narrative of 'everyone needs the highest dose' is inaccurate—effective semaglutide therapy is highly individualized.
How PlexusDx Personalizes Your Semaglutide Journey
PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides involved in appetite regulation, glucose sensing, and weight management. Specific genetic variants—like GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—predict how your body metabolizes semaglutide and whether you may respond better to lower or higher doses.
By understanding your genetic predispositions before starting treatment, PlexusDx helps your provider anticipate potential dose needs, predict tolerability, and adjust your escalation schedule proactively. This reduces trial-and-error dosing and accelerates your path to an effective maintenance dose. Compounded semaglutide from PlexusDx starts at $149 per month, and your dose may need to go up—your price won't.
Factors That Influence Your Ideal Semaglutide Dose
Your starting weight, baseline metabolic rate, concurrent medications, and liver or kidney function all shape how much semaglutide you need. Patients with type 2 diabetes may tolerate or benefit from higher doses than those using semaglutide purely for weight loss. Additionally, certain medications that slow gastric emptying or affect liver enzyme activity can interact with semaglutide, requiring dose adjustment.
Gastrointestinal tolerance remains the primary reason dose escalation pauses or reverses. If nausea, vomiting, or constipation becomes severe, your prescriber may hold at the current dose for an extra week or two, or reduce to the previous dose level. This is not treatment failure—it reflects appropriate medication management tailored to your body's signals.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the most common maintenance dose of semaglutide?
Clinical practice and trial data indicate 1.7 mg to 2.0 mg weekly is most common, though 1.0 mg remains effective for many patients. PlexusDx genetic testing helps predict whether you'll stabilize at a lower, moderate, or higher maintenance dose before you begin treatment.
Can I stay on a lower semaglutide dose if it's working?
Yes. If you achieve meaningful weight loss and feel well at 0.5 mg, 1.0 mg, or 1.7 mg, there is no clinical requirement to advance further. Your goal is sustained weight loss with acceptable side effects, not reaching the maximum labeled dose.
How often does my semaglutide dose increase?
Standard protocol increases your dose every four weeks until you reach maintenance or encounter tolerability concerns. PlexusDx compounded semaglutide injections start at $149 monthly, and your price remains flat regardless of dose level—only your medication amount changes.
What happens if I experience side effects at my current dose?
Your prescriber may pause escalation, extend the interval between dose increases, or reduce to a previously tolerated dose. Most gastrointestinal side effects improve within one to two weeks as your body adapts, but some patients genuinely require a permanent lower dose.
Does the Precision Peptide Genetic Test predict my semaglutide dose needs?
The test analyzes genetic variants affecting GLP-1 receptor function, appetite-related peptides, and metabolic rate—all factors influencing dose response. PlexusDx maps 150+ genetic insights to help your prescriber anticipate whether you'll likely respond to standard doses or require adjustment, available as a $99 add-on after your first month.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Why Is Ozempic Bad for Weight Loss? An In-Depth Look
When is Best to Inject Ozempic: Timing and Tips for Optimal Results